Immune Pharmaceuticals, Inc. - Product Pipeline Review - 2014

1
Immune Pharmaceuticals, Inc. - Product Pipeline
Review - 2014
One-Stop Shop for Business Information
2
Summary
Immune Pharmaceuticals, Inc. - Product Pipeline
Review - 2014, provides an overview of the
Immune Pharmaceuticals, Inc.s pharmaceutical
research and development focus. This report
provides comprehensive information on the current
therapeutic developmental pipeline of Immune
Pharmaceuticals, Inc.s, complete with
comparative analysis at various stages,
therapeutics assessment by drug target, mechanism
of action (MoA), route of administration (RoA)
and molecule type. It also reviews latest
updates, and featured news and press releases,
along with special features on late-stage and
discontinued projects.
3
Global Markets Directs report features
investigational drugs from across globe covering
over 20 therapy areas and nearly 3,000
indications. The report is built using data and
information sourced from Global Markets Directs
proprietary databases, Company/University
websites, SEC filings, investor presentations and
featured press releases from company/university
sites and industry-specific third party sources,
put together by Global Markets Directs team.
Drug profiles/records featured in the report
undergoes periodic updation following a stringent
set of processes that ensures that all the
profiles are updated with the latest set of
information. Additionally, processes including
live news deals tracking, browser based
alert-box and clinical trials registries tracking
ensure that the most recent developments are
captured on a real time basis .
4
The report enhances decision making capabilities
and help to create effective counter strategies
to gain competitive advantage. It strengthens RD
pipelines by identifying new targets and MOAs to
produce first-in-class and best-in-class
products.Note Certain sections in the report
may be removed or altered based on the
availability and relevance of data for the
indicated disease.Scope- The report provides
brief overview of Immune Pharmaceuticals, Inc.
including business description, key information
and facts, and its locations and subsidiaries
5
- The report reviews key players involved in the
therapeutics development for Substance (Drug)
Abuse and enlists all their major and minor
projects- The report summarizes all the dormant
and discontinued pipeline projects - A review of
the Substance (Drug) Abuse products under
development by companies and universities/research
institutes based on information derived from
company and industry-specific sources- Pipeline
products coverage based on various stages of
development ranging from pre-registration till
discovery and undisclosed stages- A detailed
assessment of monotherapy and combination therapy
pipeline projects- Coverage of the Substance
(Drug) Abuse pipeline on the basis of target,
MoA, route of administration and molecule type-
Latest news and deals relating related to
pipeline products
6
Table Of Content

• Table of Contents 2
• List of Tables 4
• List of Figures 4
• Immune Pharmaceuticals, Inc. Snapshot 5
• Immune Pharmaceuticals, Inc. Overview 5
• Key Information 5
• Key Facts 5
• Immune Pharmaceuticals, Inc. - Research and
  Development Overview 6
• Key Therapeutic Areas 6
• Immune Pharmaceuticals, Inc. - Pipeline Review 9
• Pipeline Products by Stage of Development 9
• Pipeline Products - Monotherapy 10

7

• To know more Immune Pharmaceuticals, Inc. -
  Product Pipeline Review 2014
• For Discount Reports Click Here

Contact Us-Call India 91-22-27810772/73 Call
USA/Canada (Toll Free) 1-866-279-8368 Email id
info_at_bharatbook.com